Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
15 results:

  • 1. Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
    Chen H; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Poon I; Redmond KJ; Ricardi U; Sahgal A; Louie AV
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):902-909. PubMed ID: 35753554
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
    Kijima T; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Inoue Y; Nakashima M; Iida M; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Okuno K; Nagano H
    Oncol Rep; 2017 Jan; 37(1):23-30. PubMed ID: 27878288
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer.
    Hazama S; Takenouchi H; Tsunedomi R; Iida M; Suzuki N; Iizuka N; Inoue Y; Sakamoto K; Nakao M; Shindo Y; Kanekiyo S; Tokumitsu Y; Yoshimura K; Maeda N; Maeda K; Maeda Y; Matsui H; Yoshino S; Nakamura Y; Fujita Y; Hamamoto Y; Okamoto M; Fujita T; Kawakami Y; Oka M
    Anticancer Res; 2014 Aug; 34(8):4201-5. PubMed ID: 25075047
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.
    Turcotte S; Katz SC; Shia J; Jarnagin WR; Kingham TP; Allen PJ; Fong Y; D'Angelica MI; DeMatteo RP
    Cancer Immunol Res; 2014 Jun; 2(6):530-7. PubMed ID: 24894090
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome.
    Hazama S; Nakamura Y; Takenouchi H; Suzuki N; Tsunedomi R; Inoue Y; Tokuhisa Y; Iizuka N; Yoshino S; Takeda K; Shinozaki H; Kamiya A; Furukawa H; Oka M
    J Transl Med; 2014 Mar; 12():63. PubMed ID: 24612787
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.
    Zeestraten EC; Reimers MS; Saadatmand S; Goossens-Beumer IJ; Dekker JW; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
    Br J Cancer; 2014 Jan; 110(2):459-68. PubMed ID: 24196788
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.
    Benevolo M; Mottolese M; Tremante E; Rollo F; Diodoro MG; Ercolani C; Sperduti I; Lo Monaco E; Cosimelli M; Giacomini P
    J Transl Med; 2011 Oct; 9():184. PubMed ID: 22032294
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel immunogenic hla-a*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients.
    Andrade Filho PA; López-Albaitero A; Gooding W; Ferris RL
    J Immunother; 2010 Jan; 33(1):83-91. PubMed ID: 19952953
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. hla-a, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
    Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
    Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD8 T-cell recognition of human 5T4 oncofetal antigen.
    Smyth LJ; Elkord E; Taher TE; Jiang HR; Burt DJ; Clayton A; van Veelen PA; de Ru A; Ossendorp F; Melief CJ; Drijfhout JW; Dermime S; Hawkins RE; Stern PL
    Int J Cancer; 2006 Oct; 119(7):1638-47. PubMed ID: 16646078
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
    Menon AG; Janssen-van Rhijn CM; Morreau H; Putter H; Tollenaar RA; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Lab Invest; 2004 Apr; 84(4):493-501. PubMed ID: 14968119
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Down-regulation of hla-a expression correlates with a better prognosis in colorectal cancer patients.
    Menon AG; Morreau H; Tollenaar RA; Alphenaar E; Van Puijenbroek M; Putter H; Janssen-Van Rhijn CM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
    Lab Invest; 2002 Dec; 82(12):1725-33. PubMed ID: 12480922
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Regulation of HLA class I gene expression in human colorectal carcinoma.
    Soong TW; Oei AA; Hui KM
    Semin Cancer Biol; 1991 Feb; 2(1):23-33. PubMed ID: 1912515
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
    Soong TW; Hui KM
    Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.